Cohance Lifesciences Limited
COHANCE
Rank in Stocks
#6386
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Share Price
$5.05
Last synced: 2026-10-19
Market Cap
$1.93B
Change (1 day)
-1.44%
Change (1 year)
-57.38%
Country
IN
Trade Cohance Lifesciences Limited (COHANCE)
Category
Healthcare
P/E ratio for Cohance Lifesciences Limited (COHANCE)
P/E ratio as of October 2026 TTM: 842.19
According to Cohance Lifesciences Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 842.19. At the end of 2024 the company had a P/E ratio of 56.75.
P/E ratio history for Cohance Lifesciences Limited from 2019 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 842.19 | 724.87% |
| 2025 | 102.10 | 79.89% |
| 2024 | 56.75 | 94.11% |
| 2023 | 29.24 | -15.72% |
| 2022 | 34.69 | -0.60% |
| 2021 | 34.90 | 332.36% |
| 2020 | 8.07 | -79.44% |
| 2019 | 39.26 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 34.96 | -95.85% |
IN
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.